Clinical Trial Update: A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) [Phase 3]

View source ↗

Summary

A Phase 3, placebo-controlled study evaluating LP352 in children and adults with Dravet syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• LP352

Snippet

Sponsor: Longboard Pharmaceuticals | Conditions: Dravet Syndrome | Phase 3 | Status: RECRUITING